Portfolio
Consistent with our theme of increasing specialization as a source of differentiated performance, Ampersand’s Healthcare portfolio has been focused around several overlapping industry clusters where our multiple prior successes give us a competitive edge. Most of our portfolio companies have revenues between $10 and $100 million at the time of Ampersand’s investment. We typically invest between $10 and $50 million and years of operational expertise to drive each investment toward success.
Representative companies in our current portfolio include:
-
Agilux Laboratories
Location: Worcester, MA
Business: Bioanalytical services for drug discovery and development
-
-
-
-
-
Blue Sky BioServices
Location: Worcester, MA
Business: Contract Research Organization and provider of drug discovery solutions
-
-
-
-
-
Modified Polymer Components
Location: Sunnyvale, CA
Business: Specialty plastic components for medical devices
-
Nitinol Devices & Components
Location: Fremont, CA
Business: Outsourced design and manufacturing services for the medical device industry
-
-
-
Willow Laboratories
Location: Lynn, MA
Business: Provider of alcohol and drugs of abuse toxicology testing services
Selected companies from our past portfolio include:
-
Aclara Biosciences
Location: Hayward, CA
Business: Microfluidic systems for diagnostics
Result: Acquired by LabCorp
-
Alexis
Location: San Diego, CA
Business: Reagents for life science researchers
Result: Sold to Qbiogene
-
Assay Designs
Location: Ann Arbor, MI
Business: Detection kits for drug discovery
Result: Sold to Enzo Biochem
-
CoreLab Partners
Location: Princeton, NJ
Business: Clinical trial imaging and cardiac safety
Result: Merged with BioClinica (Nasdaq: BIOC)
-
MedVenture Technology
Location: Jeffersonville, IN
Business: Outsourced developer and manufacturer of disposable medical devices
Result: Sold to Helix Medical.
-
NOVEX
Location: San Diego, CA
Business: Electrophoresis systems
Result: Sold to Invitrogen (Nasdaq: IVGN)
-
Ortho Organizers
Location: Carlsbad, CA
Business: Specialty dental products
Result: Sold to Henry Schein Inc. (Nasdaq: HSIC)
-
Panacos Pharmaceuticals (Nasdaq: PANC)
Location: Watertown, MA and Gaithersburg, MD
Business: Developer of antiviral drugs and vaccines
Result: Merged with Vitex (Nasdaq: VITX)
-
Signature Genomic Laboratories
Location: Spokane, WA
Business: Molecular cytogenetics
Result: Sold to PerkinElmer
-
Stereotaxis (Nasdaq: STXS)
Location: St. Louis, MO
Business: Magnetic-based microsurgical tools
Result: IPO
-
Talecris Biotherapeutics (Grifols, SA)
Location: Research Triangle Park, NC
Business: Pharmaceutical development and manufacturing
Result: sold to Grifols, S.A. (Nasdaq: GRFS)
-
TREK Diagnostic Systems
Location: Cleveland, OH
Business: Provider of products for microbiology labs
Result: Sold to Thermo Fisher Scientific
-
TriPath Imaging (Nasdaq: TPTH)
Location: Burlington, NC
Business: Cervical cancer screening systems
Result: AutoCyte IPO 1997. TriPath Merger 1999